Abstract

One of the core problems for people with multiple sclerosis (pwMS) is the impairment of their ability to walk, which can be severely restrictive in everyday life. Therefore, monitoring of ambulatory function is of great importance to be able to effectively counteract disease progression. An extensive gait analysis, such as the Dresden protocol for multidimensional walking assessment, covers several facets of walking impairment including a 2-min walk test, in which the distance taken by the patient in two minutes is measured by an odometer. Using this approach, it is questionable how precise the measuring methods are at recording the distance traveled. In this project, we investigate whether the current measurement can be replaced by a digital measurement method based on accelerometers (six Opal sensors from the Mobility Lab system) that are attached to the patient’s body. We developed two algorithms using these data and compared the validity of these approaches using the results from 2-min walk tests from 562 pwMS that were collected with a gold-standard odometer. In 48.4% of pwMS, we detected an average relative measurement error of less than 5%, while results from 25.8% of the pwMS showed a relative measurement error of up to 10%. The algorithm had difficulties correctly calculating the walking distances in another 25.8% of pwMS; these results showed a measurement error of more than 20%. A main reason for this moderate performance was the variety of pathologically altered gait patterns in pwMS that may complicate the step detection. Overall, both algorithms achieved favorable levels of agreement (r = 0.884 and r = 0.980) with the odometer. Finally, we present suggestions for improvement of the measurement system to be implemented in the future.

Highlights

  • Multiple sclerosis (MS) is a chronic inflammatory, progressive disease of the central nervous system

  • Our results demonstrated that the Digiwalk Algorithm (DWA) achieved a good performance in about half of the people with MS (pwMS) tested (48.4%) and the Mobility Lab Algorithm (MLA) in considerably more pwMS (77.6%)

  • An average cadence between a clinical environment and an outside environment was compared [48]. Both studies did not include a gold standard of measurement to verify the respective measurement system

Read more

Summary

Introduction

Multiple sclerosis (MS) is a chronic inflammatory, progressive disease of the central nervous system. Inflammatory lesions in the central nervous system, MS is characterized by deficits in different neurological functional systems, which leads to a wide range of symptoms and a highly individualized course of the disease [1,2]. It is important to phenotype the different symptoms of MS to adapt the management of the disease [3,4]. For many people with MS (pwMS) the limitation on the ability to walk is a clinical hallmark of their disease. Walking problems have a major impact on important areas of life and contribute significantly to the patient’s quality of life.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call